![Alexey V. Bazarov](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alexey V. Bazarov
Plus aucun poste en cours
Profil
Alexey V.
Bazarov worked as the Chief Scientific Officer at Bell Biosystems, Inc. He holds a doctorate degree from Yale University and an undergraduate degree from Cornell University.
Anciens postes connus de Alexey V. Bazarov
Sociétés | Poste | Fin |
---|---|---|
Bell Biosystems, Inc.
![]() Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Directeur Technique/Scientifique/R&D | - |
Formation de Alexey V. Bazarov
Cornell University | Undergraduate Degree |
Yale University | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 1 |
---|---|
Bell Biosystems, Inc.
![]() Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Health Technology |